Value-based primary care company Cityblock is deepening its presence with Medicaid members in North Carolina through a new partnership with Alliance Health, the companies announced Wednesday. New York ...

Deloitte’s 2026 Healthcare Outlook shows that while more than two-thirds of U.S. healthcare leaders expect to outperform competitors, rising policy uncertainty is pushing greater focus on digital care ...

More than 50 major insurers have pledged to streamline prior authorization starting in 2026, but providers remain cautiously optimistic and skeptical that the changes will truly reduce burden or ...

A coalition of major pharmacy organizations urged Congressional leaders to enact long-stalled PBM reforms to curb ...

Texas Attorney General Ken Paxton sued Epic, alleging the company monopolizes the EHR market and restricts access to medical ...

Recent changes to ACIP leadership and vaccine guidance have raised concerns that longstanding immunization protections are ...

The Senate’s rejection of two ACA-focused healthcare bills widened partisan divides and sparked warnings from advocacy groups ...

The concept of an antibody drug conjugate is straightforward enough: a cancer-killing drug payload attached to a targeting antibody that directs the molecule to cancer cells. Though these targeted ...

CMS has been trying to scale value-based care for decades with mixed results — but the agency’s newly announced ACCESS model could represent a more meaningful step toward aligning payment with ...

As healthcare costs rise, prescription drugs can be one of the costliest aspects of the healthcare experience. In an interview, RxSaveCard CEO and Founder Chris Crawford talked about his new business ...

Astellas Pharma is hunting for drugs to make up for the decline in revenue facing its top-selling product as it loses patent protection in the next few years. It sees a strong contender in an Iveric ...

Rare disease drug developer BioMarin Pharmaceutical is buying its way to revenue growth with a $4.8 billion deal for Amicus Therapeutics, a company whose two commercialized products each offer ...